[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Rossi et al., 2008 - Google Patents

Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome

Rossi et al., 2008

View HTML
Document ID
12310975508120659088
Author
Rossi B
Sukalich S
Droz J
Griffin A
Cook S
Blumkin A
Guzick D
Hoeger K
Publication year
Publication venue
The Journal of Clinical Endocrinology & Metabolism

External Links

Snippet

Context: Adults with polycystic ovary syndrome (PCOS) may be at increased risk for metabolic syndrome (MBS) and related cardiovascular disease. It is not clear whether PCOS diagnosed in adolescence increases the risk of MBS in this age group. Objective: The aim …
Continue reading at academic.oup.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Similar Documents

Publication Publication Date Title
Rossi et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome
Christian et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome
Talbott et al. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome
Aust et al. Vaspin serum concentrations in patients with carotid stenosis
Raji et al. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians
Vryonidou et al. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome
Heitritter et al. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus
Langsted et al. Lipoprotein (a): fasting and nonfasting levels, inflammation, and cardiovascular risk
Davis et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review
Meun et al. The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
Goran et al. Impaired glucose tolerance and reduced β-cell function in overweight Latino children with a positive family history for type 2 diabetes
Adeney et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD
Athyros et al. Prevalence of vascular disease in metabolic syndrome using three proposed definitions
Iacobellis et al. Adipokines and cardiometabolic profile in primary hyperaldosteronism
Barreto-Filho et al. Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia
Joham et al. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance
Van Dijk et al. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (SGA) and untreated short SGA controls
Heussinger et al. 10 patients, 10 years–Long term follow-up of cardiovascular risk factors in Glut1 deficiency treated with ketogenic diet therapies: A prospective, multicenter case series
Tatami et al. Impact of abdominal aortic calcification on long-term cardiovascular outcomes in patients with chronic kidney disease
Kawachi et al. Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis
Singh et al. Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function
Shields et al. Perivascular adipose tissue of the descending thoracic aorta is associated with systemic lupus erythematosus and vascular calcification in women
Guillemette et al. TNFα dynamics during the oral glucose tolerance test vary according to the level of insulin resistance in pregnant women
Beulens et al. Alcohol consumption and risk of recurrent cardiovascular events and mortality in patients with clinically manifest vascular disease and diabetes mellitus: the Second Manifestations of ARTerial (SMART) disease study
He et al. Metabolic and nutritional characteristics in middle‐aged and elderly sarcopenia patients with type 2 diabetes